Scotch Plains, NJ, United States of America

Thierry Olivier Fischmann

This inventor holds 22 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Pharmacopeia Drug Discovery, Inc.. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thierry Olivier Fischmann. Retrieved from https://idiyas.com/inventor/thierry-olivier-fischmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 4)

% Patents Active = 72.7

CIPO Patents = 3

EPO Patents = 11 (Patent Applications = 4)

Average Co-Inventor Count = 11.6

ph-index = 7

Forward Citations = 119(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

3 out of 52

Pharmacopeia Drug Discovery, Inc.

Merck Sharp + Dohme B.v.

patents

where one patent can have more than one assignee

Years Active: 2006-2020

Loading Chart...

Areas of Expertise:

Anti-CD27 Antibodies

IRAK4 Activity Inhibitors

Anilinopiperazine Derivatives

Cyclin Dependent Kinase Inhibitors

3-Phosphoinositide-Dependent Protein Kinase-1

Aurora 2 Kinase

N-Heteroaryl Pyrazolopyrimidines

Polynucleotides

AKT3 Polypeptides

Quinoline-Based Ligands

Trisubstituted 4-Aminopyrazolopyrimidines

Pyrazolopyrimidines

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10556957 - Anti-CD27 antibodies (2020-02-11),

2. 9969749 - Inhibitors of IRAK4 activity (2018-05-15),

3. 9943516 - Inhibitors of IRAK4 activity (2018-04-17),

4. 9932350 - Inhibitors of IRAK4 activity (2018-04-03),

5. 9926330 - Inhibitors of IRAK4 activity (2018-03-27),

6. 9206142 - Anilinopiperazine derivatives and methods of use thereof (2015-12-08),

7. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),

8. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 (2014-01-07),

9. 8440443 - MEK1 polypeptides (2013-05-14),

10. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-11-27),

11. 8227605 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-07-24),

12. 8088611 - Kinase domain polypeptide of human protein kinase B gamma (AKT3) (2012-01-03),

13. 7824491 - Method for crystallizing aurora 2 kinase catalytic domain polypeptide (2010-11-02),

14. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors (2010-10-05),

15. 7776589 - Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3) (2010-08-17),

Title: Thierry Olivier Fischmann: Pioneering Innovator in the World of Patents and Inventions

Introduction:

Thierry Olivier Fischmann, a renowned inventor based in Scotch Plains, NJ, has made significant contributions to the world of patents and inventions through his passion for innovation and unwavering commitment to excellence. With 22 patents to his name, Fischmann's work continues to inspire the next generation of inventors worldwide.

Latest Patents:

Fischmann's latest patents include groundbreaking innovations such as Anti-CD27 antibodies, which hold promise in the treatment of diseases like cancer and infectious diseases. Additionally, his work on Inhibitors of IRAK4 activity showcases his dedication to developing novel therapeutics for IRAK4-mediated conditions.

Career Highlights:

Throughout his career, Fischmann has held pivotal roles at leading companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His expertise and innovative approach have played a key role in the development of cutting-edge technologies and groundbreaking inventions in the pharmaceutical industry.

Collaborations:

Fischmann's impactful work has been further amplified through collaborations with esteemed colleagues like Vincent Stewart Madison and Timothy J Guzi. Together, they have driven forward innovative solutions that have the potential to revolutionize the field of medicine and healthcare.

Conclusion:

In conclusion, Thierry Olivier Fischmann stands as a visionary inventor whose contributions have reshaped the landscape of patents and inventions. His relentless pursuit of excellence and passion for innovation serve as a beacon of inspiration for inventors around the globe, leaving behind a lasting legacy that will continue to shape the future of technology and healthcare.

Profile summary based on public USPTO records.